Fayez Sarofim & Co’s Omega Healthcare OHI Stock Holding History

Fayez Sarofim & Co’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,555	Closed	-$855K	–	317
2021 Q2	$855K	Buy	+23,555	New	+$875K	﹤0.01%	223

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fayez Sarofim & Co's OHI Position: Q3 2021 in Review

Fayez Sarofim & Co sold out of Omega Healthcare (OHI) in Q3 2021, closing a stake of 23,555 shares — an estimated $855K sold.

Fayez Sarofim & Co first reported a position in OHI in Q2 2021 and held it in 1 quarter. The position peaked at $855K in Q2 2021. 508 funds tracked by Wall St. Rank hold OHI as of Q3 2021.

Fayez Sarofim & Co reported no remaining Omega Healthcare position as of Q3 2021 after selling out during the quarter.
Fayez Sarofim & Co sold 23,555 Omega Healthcare shares in Q3 2021, an estimated $855K.
Fayez Sarofim & Co first reported a position in Omega Healthcare in Q2 2021 and held it in 1 quarter.
Fayez Sarofim & Co's Omega Healthcare position peaked at $855K in Q2 2021.
508 funds tracked by Wall St. Rank held Omega Healthcare as of Q3 2021.

Based on Fayez Sarofim & Co's 13F filing for Q3 2021, filed 15 Nov 2021.